| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.3 | 5e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.26 | 7e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |